Mustang Bio Inc (NASDAQ:MBIO) shares, rose in value on Wednesday, June 18, with the stock price up by 4.90% to the previous day’s close as strong demand from buyers drove the stock to $1.07.
Actively observing the price movement in the last trading, the stock closed the session at $1.02, falling within a range of $1.02 and $1.1. The value of beta (5-year monthly) was 2.245. Referring to stock’s 52-week performance, its high was $65.00, and the low was $1.01. On the whole, MBIO has fluctuated by -7.76% over the past month.
With the market capitalization of Mustang Bio Inc currently standing at about $4.69 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-28.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MBIO’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MBIO currently trading nearly -13.71% and -12.57% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.97, while the 7-day volatility ratio is showing 6.22% which for the 30-day chart, stands at 4.12%. Furthermore, Mustang Bio Inc (MBIO)’s beta value is 2.24, and its average true range (ATR) is 0.08.
A comparison of Mustang Bio Inc (MBIO) with its peers suggests the former has fared considerably weaker in the market. MBIO showed an intraday change of 4.90% in last session, and over the past year, it shrunk by -83.54%%.
Data on historical trading for Mustang Bio Inc (NASDAQ:MBIO) indicates that the trading volumes over the past 10 days have averaged 92170.0 and over the past 3 months, they’ve averaged 397.03K. According to company’s latest data on outstanding shares, there are 4.38 million shares outstanding.
Nearly 28.11% of Mustang Bio Inc’s shares belong to company insiders and institutional investors own 2.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 97080.0 shares as on 2025-05-30, resulting in a short ratio of 0.65. According to the data, the short interest in Mustang Bio Inc (MBIO) stood at 275.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.2 million. The stock has fallen by -87.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MBIO stock heading into the next quarter.
